Steven Kanzer

Directeur/Membre du Conseil chez Effective Pharmaceuticals, Inc.

Profil

Steven H.
Kanzer founded Theriva Biologics, Inc. in 2001, where he worked as Director from 2001 to 2014.
Mr. Kanzer also founded Avigen, Inc. and Developmental Therapeutics, Inc., where he worked as Chairman, President & Chief Executive Officer in 2003.
Mr. Kanzer also currently works at Effective Pharmaceuticals, Inc., as Director from 2000, CD4 Biosciences, Inc., as Director from 2000, and Epitope Pharmaceuticals, Inc., as Director.
Mr. Kanzer also formerly worked at Sheffield Pharmaceuticals, Inc., as Chief Executive Officer, Institute for Drug Research, as Chief Executive Officer in 1999, Pipex Therapeutics, Inc., as Chairman & Chief Executive Officer, Soligenix, Inc., as Non-Executive Vice Chairman from 1996 to 2007, Windtree Therapeutics, Inc., as Chairman, Licensing Executives Society, as Co-Chairman, Paramount Capital, Inc., as Senior Managing Director, Solovax, Inc., as Director from 2011 to 2014, Putney Drug Corp., as Director from 2000 to 2014, and PolaRx Biopharmaceuticals, as President.
Mr. Kanzer received his graduate degree in 1988 from New York University and undergraduate degree in 1985 from Baruch College.

Postes actifs de Steven Kanzer

Sociétés	Poste	Début
Effective Pharmaceuticals, Inc.	Directeur/Membre du Conseil	18/05/2010
CD4 Biosciences, Inc.	Directeur/Membre du Conseil	18/05/2010
Epitope Pharmaceuticals, Inc.	Directeur/Membre du Conseil	11/04/2011

Anciens postes connus de Steven Kanzer

Sociétés	Poste	Fin
THERIVA BIOLOGICS, INC.	Fondateur	26/02/2014
Pipex Therapeutics, Inc.	Directeur Général	26/02/2014
Solovax, Inc.	Directeur/Membre du Conseil	26/02/2014
Putney Drug Corp.	Directeur/Membre du Conseil	26/02/2014
SOLIGENIX, INC.	Directeur/Membre du Conseil	28/05/2007